1.Brinsley, K, Srinivasan, A, Sinkowitz-Cochran, R, et al. Implementation of the campaign to prevent antimicrobial resistance in healthcare settings: 12 steps to prevent antimicrobial resistance among hospitalized adults— experiences from 3 institutions. Am J Infect Control 2005; 33:53–54.
2.Monnet, DL, Archibald, LK, Phillips, L, Tenover, FC, McGowan, JE Jr, Gaynes, RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998; 19:388–394.
3.Krueger, RA. Focus Groups: A Practical Guide for Applied Research. 2nd ed. Thousand Oaks, CA: Sage Publications; 1994.
4.Mandell, LA, Bartlett, JG, Dowell, SF, File, TM Jr, Musher, DM, Whitney, C. Update of practice guidelines for the management of communityacquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405–1433.
5.National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470–485.
6.Solomkin, JS, Mazuski, JE, Baron, EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003;37:997–1005.
7.Lipsky, BA, Berendt, AR, Deery, HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885–910.
8.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234–240.